menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'Oncology/Hematology' ×
Forrest Anthony
FDA unanimously recommends approving this gene altering therapy for pediatric lymphoblastic leukemia.
Read More
Forrest Anthony
Targeted therapies continue to churn out new oncology treatments meeting unmet medical needs among cancer patients around the world.
Read More
Forrest Anthony
Forrest Anthony
How Adoptive Cellular Therapy could change the standard of care for cancer patients around the world.
Read More
Forrest Anthony
Targeted therapies continue to churn out new oncology treatments meeting unmet medical needs among cancer patients around the world.
Read More
Jeff Keefer
How patient reported outcomes and global trials are giving new hope to sickle cell disease patients who haven’t seen a new treatment in decades.
Read More
Brad Smith
Kimberly Ray
Why targeted oncology research requires a more precise approach to clinical trial design.
Read More
Peter Rutherford
Biopharma need to remember the patient – the “end user” – when developing materials, education and support mechanisms that accompany treatments.
Read More
Terry Murdock
How checkpoint inhibitors help targeted cancer therapies reach their destination – better patient outcomes.
Read More